Evidence map›Paper›PMID 39082176›Full record

ArticleEndocrine, metabolic & immune disorders drug targets2025

Impact of Luteinizing Hormone on IVF/ICSI Assisted Reproduction on the Initiation Day of Gonadotropin-releasing Hormone Antagonist Protocol.

Li-Jia Zhang, Dun Liu, Li-Qing Xu, Jin-Yan Wei, Lin Fan, Xi-Qian Zhang, Feng-Hua Liu

Abstract read
PubMed Publisher
In one paragraph

Article in Endocrine, metabolic & immune disorders drug targets, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Li-Jia ZhangDepartment of Reproductive Medical Center, Guangdong Women and Children Hospital, Guangzhou, Guangdong Province, China.
Dun LiuDepartment of Reproductive Medical Center, Guangdong Women and Children Hospital, Guangzhou, Guangdong Province, China.
Li-Qing XuDepartment of Reproductive Medical Center, Guangdong Women and Children Hospital, Guangzhou, Guangdong Province, China.
Jin-Yan WeiDepartment of Reproductive Medical Center, Guangdong Women and Children Hospital, Guangzhou, Guangdong Province, China.
Lin FanDepartment of Reproductive Medical Center, Guangdong Women and Children Hospital, Guangzhou, Guangdong Province, China.
Xi-Qian ZhangDepartment of Reproductive Medical Center, Guangdong Women and Children Hospital, Guangzhou, Guangdong Province, China.
Feng-Hua LiuDepartment of Reproductive Medical Center, Guangdong Women and Children Hospital, Guangzhou, Guangdong Province, China.

Funding

Guangdong Maternal and Child Health Hospital 202401262Guangzhou Science and Technology Plan Project 202102020449, 202201011058, 202102021170
6 · The paper itself

Abstract

objectiveThe aim of the study was to explore the optimal timing of gonadotropin initiation and the reasonable interval of luteinizing hormone (LH) level in the gonadotropin-releasing hormone antagonist (GnRH-A) protocol.

methodsA retrospective cohort study was conducted to analyze the LH level in patients with different ovarian response treated in GnRH-A protocol in 1361 IVF/ICSI cycles. Ovarian response (including AMH, AFC) in these patients were divided into the poor ovarian response group (an antral follicle count (AFC) ≤ 6, n = 394), the normal ovarian response group (an AFC > 6 and < 15, n = 570), and the high ovarian response group (an AFC ≥ 15, n = 397), according to the AFC. The patients were sub-grouped according to LH levels on the protocol initiation day, and the clinical outcomes (including dose of Gn initiation, Gn administration days, GnRH-ant administration days, P levels on the HCG day, E2 levels on the HCG day, LH levels on the HCG day, number of embryos transferred, total fertilization rate, embryo implantation rate (%), proportion of 2PN, proportion of good-quality embryos, endometrial thickness on the hCG injection day (mm), moderate to severe OHSS, AFC on the initiation day, proportion of type A endometrium on the hCG injection day, clinical pregnancy rate, biochemical pregnancy rate, early abortion rate, ectopic pregnancy rate) were compared.

resultsOn the GnRH-A protocol initiation day, among all patients with different ovarian responses, the body mass index (BMI) in those with an LH ≥ 5 IU/L was lower. The difference of pregnancy outcome between the LH < 5 IU/L group and the LH ≥ 5 IU/L group were not statistically significant among the different ovarian response groups, but the LH < 5 IU/L group had a higher proportion of good-quality embryos (80.3 ± 24.9 vs. 74.8 ± 26.9, P =0.035) than the LH≥5IU/Lgroup in those with poor ovarian response. The total fertilization rate (82.2 ± 18.1 vs 85.4 ± 15.1, P =0.021) and proportion of two pronuclei (2PN) (69.0 ± 20.9 vs 72.7 ± 19.9, P =0.035) were higher in the LH ≥ 5 IU/L group than the LH<5 IU/L group for those with normal ovarian response. The embryo implantation rate (41.4 ± 41.3 vs 52.6 ± 43.4, P =0.012) was higher in the LH ≥ 5 IU/L group than in the LH<5 IU/L group in those with high ovarian response. The results of the multivariate logistic analysis showed that the age of the female partner, number of embryos transferred, proportion of good-quality embryos, endometrial thickness on the hCG injection day, and moderate-to-severe ovarian hyperstimulation syndrome (OHSS) were independent factors correlated with the outcome of live births (P < 0.05).

conclusionThe LH levels on the gonadotropins (Gn) initiation day in GnRH-A protocol will not affect pregnancy outcomes.

Indexed as

Fertilization in VitroGonadotropin-Releasing HormoneHormone AntagonistsLuteinizing HormoneOvulation InductionSperm Injections, IntracytoplasmicAdultCohort StudiesFemaleHumansPregnancyPregnancy RateRetrospective StudiesTime FactorsGonadotropin-Releasing HormoneHormone AntagonistsLuteinizing HormoneGonadotropin-releasing hormoneIVF/ICSI .luteinizing hormoneoocyte retrievalovarianpregnancy outcome

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.